Citadel Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7065 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7104 |
|
|
2022
Q2 | – | Sell |
-20,368
| Closed | -$7K | – | 7351 |
|
|
2022
Q1 | $7K | Buy |
+20,368
| New | +$7K | ﹤0.01% | 6226 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7538 |
|
|
2021
Q2 | – | Sell |
-36,626
| Closed | -$192K | – | 7371 |
|
|
2021
Q1 | $192K | Buy |
36,626
+25,471
| +228% | +$134K | ﹤0.01% | 5447 |
|
|
2020
Q4 | $38K | Buy |
+11,155
| New | +$38K | ﹤0.01% | 4904 |
|
|
2020
Q2 | – | Sell |
-12,009
| Closed | -$20K | – | 5501 |
|
|
2020
Q1 | $20K | Buy |
+12,009
| New | +$20K | ﹤0.01% | 4667 |
|
|
2019
Q4 | – | Sell |
-28,435
| Closed | -$29K | – | 5290 |
|
|
2019
Q3 | $29K | Buy |
+28,435
| New | +$29K | ﹤0.01% | 4460 |
|
|
2018
Q3 | – | Sell |
-15,389
| Closed | -$38K | – | 4870 |
|
|
2018
Q2 | $38K | Buy |
15,389
+1,888
| +14% | +$4.66K | ﹤0.01% | 3945 |
|
|
2018
Q1 | $41K | Buy |
+13,501
| New | +$41K | ﹤0.01% | 3778 |
|
|
2017
Q4 | – | Sell |
-10,032
| Closed | -$35K | – | 4401 |
|
|
2017
Q3 | $35K | Sell |
10,032
-5,686
| -36% | -$19.8K | ﹤0.01% | 3447 |
|
|
2017
Q2 | $46K | Buy |
+15,718
| New | +$46K | ﹤0.01% | 3404 |
|
|
2016
Q4 | – | Sell |
-29,899
| Closed | -$52K | – | 4259 |
|
|
2016
Q3 | $52K | Buy |
+29,899
| New | +$52K | ﹤0.01% | 3282 |
|
|
2014
Q4 | – | Sell |
-2,386
| Closed | -$22K | – | 4049 |
|
|
2014
Q3 | $22K | Buy |
+2,386
| New | +$22K | ﹤0.01% | 3271 |
|
|
2014
Q1 | – | Sell |
-427
| Closed | -$10K | – | 3802 |
|
|
2013
Q4 | $10K | Sell |
427
-158
| -27% | -$3.7K | ﹤0.01% | 3007 |
|
|
2013
Q3 | $18K | Buy |
585
+273
| +88% | +$8.4K | ﹤0.01% | 2781 |
|
|
2013
Q2 | $10K | Buy |
+312
| New | +$10K | ﹤0.01% | 2702 |
|